Hospital-based and independent labs are increasingly challenged by depressed volume, declining payment rates, and market disruptions.
Courtney Midanek is a leader in Kaufman Hall’s Mergers and Acquisitions practice, with more than 20 years of experience in capital markets, valuations, and M&A. She provides partnership advisory services for a variety of healthcare clients in both acute and non-acute care.
Prior to Kaufman Hall, Courtney was in the Business Expansion Group of the Blue Cross and Blue Shield Association (BCBSA), where she supported strategic asset and partnership initiatives for BCBSA and the BCBS Plans. She previously held various roles at BMO Capital Markets, with a focus on M&A in the Corporate Development Group. Courtney began her career as an industry generalist in the M&A advisory group of Robert W. Baird & Co.
She holds an M.B.A. from Northwestern University, with concentrations in Finance, Management, and Strategy.
Insights from Courtney Midanek
Until recently, many hospital and health systems have counted on relatively stable margins from outreach laboratory departments. However, the economics of lab testing are changing dramatically due to depressed volume, declining payment rates, and accelerated consolidation.